Similar articles

• Intraperitoneal infusion of ultrafiltered ascites in decompensated cirrhosis of the liver; preliminary investigation. II.

  ADLERCREUTZ E. ADLERCREUTZ E. Acta Med Scand. 1958 May 16;161(1):9-20. doi: 10.1111/j.0954-6820.1958.tb15517.x. Acta Med Scand. 1958. PMID: 13532481 No abstract available.
• Evaluation of Talbot's safety zone of infusion volume and osmolality in infusion therapy for decompensated liver cirrhosis.

  Yuasa S, Itoshima T, Ono R, Nagashima H. Yuasa S, et al. Acta Med Okayama. 1985 Jun;39(3):179-90. doi: 10.18926/AMO/31531. Acta Med Okayama. 1985. PMID: 4024992
• Concentration-reinfusion (CR) of ascitic of ascitic fluid in the treatment of decompensated liver cirrhosis with diuretic-resistant ascites.

  Ventura E, Zeneroli ML. Ventura E, et al. Postgrad Med J. 1975 Aug;51(598):577-80. doi: 10.1136/pgmj.51.598.577. Postgrad Med J. 1975. PMID: 1234346 Free PMC article.
• Albumin infusion in liver cirrhotic patients.

  Rena NM, Wibawa ID. Rena NM, et al. Acta Med Indones. 2010 Jul;42(3):162-8. Acta Med Indones. 2010. PMID: 20724771 Review.
• Management of ascites in patients with end-stage liver disease.

  Saadeh S, Davis GL. Saadeh S, et al. Rev Gastroenterol Disord. 2004 Fall;4(4):175-85. Rev Gastroenterol Disord. 2004. PMID: 15580152 Review.